Ionis Pharmaceuticals (IONS) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -4.89 | 6.65 | 45.4 | 1.14 | 2.72 | 0.31 | |||
Changes by years, y/y, % | -120% | -236% | +584% | -97% | +138% | -35.6% |
Ionis Pharmaceuticals. Debt/EBITDA
Ionis Pharmaceuticals. Debt/EBITDA, changes, %
Ionis Pharmaceuticals (IONS) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 1.61 | 1.31 | 3.13 | 0.72 | 0.31 | 0.31 | ||
Changes by years, y/y, % | -101% | -105% | +171% | -56% | -81% | |||
Changes by quarters, q/q, % | -2% | -19% | +139% | -77% | -57% |